chiroscience gains first drug approval

22

Chirosdmce gain<; first drug approval

The UK biotechnology company Chiroscience hasachieved its first regulatory success with the approvalof its analgesic dc:xkc:top rofen in Spain, report Scripandthe Financial nmes.1,2

Dexketoprofen, which is the single d· jsomerversion of ketoprofen , is to be marketed in Spai n bycodeveloper Menarini as 'Enantyum' . The launch ofdexketoprofen in that country is expected by the endof this year and further European appro vals of thedrug are anticipated in 1996 and early 1997.according to the Financial 1imes.2 Dexketoprotencould have worldwide sales of about £7S million/year.predict analysts at Lehman Brothers.

An I-isomer version of bupivacame. levobupivacaine,is likely to be the next Chiroscic:nce productto beapproved internationally.

I. PtoducI: DewS ill briet. t'Inl~ fur Cbio...ic:a:e. Scrip 2074, 14, 3 NooI~ .1. Grra D. Biolodl COIJf'I"y-...a IIlllfO'"IJ 101 tint dNa- FiDaDci.IJnmcr. ;4. 28·29 Oo;.t I~ _ .....

01!16-270Ml51'I0 12-ooo221$Ol .orf' Allis Intemillo..-l LlmlWd 11K15. All r~ .-ved